Veracyte expands Decipher Prostate Test availability for metastatic prostate cancer patients
April 25, 2025
Veracyte, Inc. , a leading genomic diagnostics company, announced the launch of its Decipher Prostate Metastatic Genomic Classifier for use in patients whose prostate cancer has